225 related articles for article (PubMed ID: 16368752)
21. Mechanism of repression of 11β-hydroxysteroid dehydrogenase type 1 by growth hormone in 3T3-L1 adipocytes.
Muraoka T; Hizuka N; Fukuda I; Ishikawa Y; Ichihara A
Endocr J; 2014; 61(7):675-82. PubMed ID: 24759003
[TBL] [Abstract][Full Text] [Related]
22. Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
Tomlinson JW; Crabtree N; Clark PM; Holder G; Toogood AA; Shackleton CH; Stewart PM
J Clin Endocrinol Metab; 2003 May; 88(5):2113-8. PubMed ID: 12727963
[TBL] [Abstract][Full Text] [Related]
23. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
Thompson A; Han VK; Yang K
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
[TBL] [Abstract][Full Text] [Related]
26. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
27. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
[TBL] [Abstract][Full Text] [Related]
28. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
Stegk JP; Ebert B; Martin HJ; Maser E
Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
[TBL] [Abstract][Full Text] [Related]
29. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
[TBL] [Abstract][Full Text] [Related]
30. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
[TBL] [Abstract][Full Text] [Related]
31. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
[TBL] [Abstract][Full Text] [Related]
32. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake DJ; Hamsten A; Walker BR; Yki-Järvinen H
Diabetologia; 2004 Oct; 47(10):1668-71. PubMed ID: 15455200
[TBL] [Abstract][Full Text] [Related]
33. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
[TBL] [Abstract][Full Text] [Related]
34. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
Toogood AA; Taylor NF; Shalet SM; Monson JP
J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
[TBL] [Abstract][Full Text] [Related]
35. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
[TBL] [Abstract][Full Text] [Related]
36. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
Wang J; Sun B; Hou M; Pan X; Li X
Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
[TBL] [Abstract][Full Text] [Related]
37. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
39. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
[TBL] [Abstract][Full Text] [Related]
40. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]